Showing 6401-6410 of 10618 results for "".
- CRT-Guided Resuscitation Improves Hierarchical Outcomes in Early Septic Shockhttps://reachmd.com/news/capillary-refill-time-early-septic-shock/2486923/Key Takeaways CRT-PHR was associated with a favorable 28-day hierarchical outcome versus usual care in early septic shock. Early resuscitation under CRT-PHR involved less fluid, more dobutamine use, lower central venous pressure and lactate, and more f
- RAAS Inhibition vs Calcium Channe Blockade in Pediatric CKDhttps://reachmd.com/news/raas-inhibition-vs-ccb-in-pediatric-ckd/2486907/Key Takeaways First-line RAAS inhibition was associated with fewer kidney replacement therapy events over 2 years than calcium channel blockade. RAAS inhibition was also associated with a lower secondary kidney composite risk and less time with systoli
- UACR And UPCR In CKD Trials: Kidney Failure Riskhttps://reachmd.com/news/uacr-upcr-ckd-trials-kidney-failure-risk/2486897/Key Takeaways UACR AND UPCR were strongly associated with kidney failure, with UACR showing the stronger pooled association. The difference was clearest in type 2 diabetes and CKD and less clear in glomerular disease. In a
- FAPI-Guided Surgery In Medullary Thyroid Carcinoma Shows Promising Resultshttps://reachmd.com/news/fapi-guided-surgery-in-medullary-thyroid-carcinoma-shows-promising-results/2486834/Key Takeaways PET-CT findings were associated with operative-plan changes in 46% of patients, and 91% of those changes were later supported by histopathology. Biochemical cure at 1 month was observed in the two R0 resection arms, at 84.2% in newly diag
- Extended-Release vs Sublingual Buprenorphine in Pregnancy and Postpartumhttps://reachmd.com/news/extended-release-vs-sublingual-buprenorphine-in-pregnancy-and-postpartum/2486841/Key Takeaways Extended-release buprenorphine was associated with higher illicit opioid abstinence during pregnancy. Abstinence declined postpartum and appeared similar in the two treatment groups. Serious adverse events were less frequent with
- Rapid Blood Infection Test Fails To Improve Survivalhttps://reachmd.com/news/rapid-blood-infection-test-fails-to-improve-survival/2486815/Key Takeaways Rapid testing was not superior to standard susceptibility testing for 30-day clinical outcomes, including mortality, in gram-negative bloodstream infection. Faster overall antibiotic escalation or de-escalation was observed, along with mo
- Revance Highlights RHA Dynamic Volume Mid-Face FDA Approval at Virtual Desk Sidehttps://reachmd.com/news/revance-highlights-rha-dynamic-volume-mid-face-fda-approval-at-virtual-desk-side/2486819/Revance Aesthetics hosted a virtual desk side with Lesley Clark-Loeser, MD, to discuss the recent US Food and Drug Administration (FDA) approval of RHA Dynamic Volume for cheek augmentation and correction of age-related mid-face contour deficiencies in adults aged 22 years and older. The a
- Avacincaptad Pegol Two-Year GATHER2 Results in Geographic Atrophyhttps://reachmd.com/news/avacincaptad-pegol-two-year-gather2-results-in-geographic-atrophy/2486781/Key Takeaways Both year-2 avacincaptad pegol dosing schedules were associated with less geographic atrophy growth than sham at 2 years. Patients receiving avacincaptad pegol were rerandomized at month 12 to monthly or every-other-month dosing, and both
- Home-Based Prehabilitation In Frail Older Surgical Patientshttps://reachmd.com/news/home-based-prehabilitation-in-frail-older-surgical-patients/2486782/Key Takeaways The primary analyses showed no between-group differences in postoperative disability or in-hospital complications. The intervention was a home-based, multimodal, coach-supported program, and adherence was feasible but incomplete, with med
- Omalizumab Linked to 16-Week Gains in Severe Allergic Asthmahttps://reachmd.com/news/omalizumab-linked-to-16-week-gains-in-severe-allergic-asthma/2486790/Key Takeaways Omalizumab was associated with better asthma control, less dyspnea, and a longer 6-minute walk distance at week 16. FeNO was lower, serum IgE was higher, and peak expiratory flow and mid- to small-airway flow measures improved. L